The prothrombin consumption test measures the formation of intrinsic thromboplastin by determining the residual serum prothrombin after blood clotting is complete. If there is a defect in the process, less prothrombin will be converted to thrombin than normal (less prothrombin is consumed). This test may be abnormal with conditions including deficiency of factors VIII or IX, with circulating anticoagulants, thrombocytopenia. (Human Phenotype Ontology, HP_0003337)
1 genes associated with the reduced prothrombin consumption phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
